297 related articles for article (PubMed ID: 10766188)
1. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels.
Chavanne F; Broughton BC; Pietra D; Nardo T; Browitt A; Lehmann AR; Stefanini M
Cancer Res; 2000 Apr; 60(7):1974-82. PubMed ID: 10766188
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms.
Kobayashi T; Kuraoka I; Saijo M; Nakatsu Y; Tanaka A; Someda Y; Fukuro S; Tanaka K
Hum Mutat; 1997; 9(4):322-31. PubMed ID: 9101292
[TBL] [Abstract][Full Text] [Related]
3. In vivo destabilization and functional defects of the xeroderma pigmentosum C protein caused by a pathogenic missense mutation.
Yasuda G; Nishi R; Watanabe E; Mori T; Iwai S; Orioli D; Stefanini M; Hanaoka F; Sugasawa K
Mol Cell Biol; 2007 Oct; 27(19):6606-14. PubMed ID: 17682058
[TBL] [Abstract][Full Text] [Related]
4. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
[TBL] [Abstract][Full Text] [Related]
5. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the XPD gene in xeroderma pigmentosum group D cell strains: confirmation of genotype-phenotype correlation.
Kobayashi T; Uchiyama M; Fukuro S; Tanaka K
Am J Med Genet; 2002 Jul; 110(3):248-52. PubMed ID: 12116233
[TBL] [Abstract][Full Text] [Related]
8. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
9. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC.
Sands AT; Abuin A; Sanchez A; Conti CJ; Bradley A
Nature; 1995 Sep; 377(6545):162-5. PubMed ID: 7675084
[TBL] [Abstract][Full Text] [Related]
10. Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein.
States JC; McDuffie ER; Myrand SP; McDowell M; Cleaver JE
Hum Mutat; 1998; 12(2):103-13. PubMed ID: 9671271
[TBL] [Abstract][Full Text] [Related]
11. Genotype-specific Trp53 mutational analysis in ultraviolet B radiation-induced skin cancers in Xpc and Xpc Trp53 mutant mice.
Reis AM; Cheo DL; Meira LB; Greenblatt MS; Bond JP; Nahari D; Friedberg EC
Cancer Res; 2000 Mar; 60(6):1571-9. PubMed ID: 10749125
[TBL] [Abstract][Full Text] [Related]
12. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor.
Gozukara EM; Khan SG; Metin A; Emmert S; Busch DB; Shahlavi T; Coleman DM; Miller M; Chinsomboon N; Stefanini M; Kraemer KH
J Invest Dermatol; 2001 Aug; 117(2):197-204. PubMed ID: 11511294
[TBL] [Abstract][Full Text] [Related]
13. A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients.
Cartault F; Nava C; Malbrunot AC; Munier P; Hebert JC; N'guyen P; Djeridi N; Pariaud P; Pariaud J; Dupuy A; Austerlitz F; Sarasin A
DNA Repair (Amst); 2011 Jun; 10(6):577-85. PubMed ID: 21482201
[TBL] [Abstract][Full Text] [Related]
14. High frequency of the V548A fs X572 XPC mutation in Tunisia: implication for molecular diagnosis.
Ben Rekaya M; Messaoud O; Talmoudi F; Nouira S; Ouragini H; Amouri A; Boussen H; Boubaker S; Mokni M; Mokthar I; Abdelhak S; Zghal M
J Hum Genet; 2009 Jul; 54(7):426-9. PubMed ID: 19478817
[TBL] [Abstract][Full Text] [Related]
15. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
16. The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect.
Berneburg M; Clingen PH; Harcourt SA; Lowe JE; Taylor EM; Green MH; Krutmann J; Arlett CF; Lehmann AR
Cancer Res; 2000 Jan; 60(2):431-8. PubMed ID: 10667598
[TBL] [Abstract][Full Text] [Related]
17. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
18. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
19. Ultraviolet B radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (HAP1) genes: genotype-specific effects on cancer predisposition and pathology of tumors.
Cheo DL; Meira LB; Burns DK; Reis AM; Issac T; Friedberg EC
Cancer Res; 2000 Mar; 60(6):1580-4. PubMed ID: 10749126
[TBL] [Abstract][Full Text] [Related]
20. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.
Armelini MG; Muotri AR; Marchetto MC; de Lima-Bessa KM; Sarasin A; Menck CF
Cancer Gene Ther; 2005 Apr; 12(4):389-96. PubMed ID: 15650764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]